Initial and Follow‐Up Results of the Tenax Coronary Stent
Authors:
- Didier CarriéDCDidier Carrié
- Jean PierreJPJean Pierre
- 1 February 2001
- journal article
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 14 (1) , 1-5
Abstract
The Tenax coronary stent is laser sculpted from high precision 316 L stainless steel using advanced production procedures. An a‐Sic : H (hydrogen‐rich amorphous silicon carbide) coating reduces its thrombogenicity and improves its biocomputibility. From April to July 1998, 266 stents were implanted in 241 patients (aged 62.7 ± 10.8 years) in five centers. The clinical indication for intervention was unstable angina (33.2%) and recent myocardial infarction (29.8%) in many cases. Most lesions (83.8%) had complex characteristics (Class B2 or C). The target vessel was the LAD in 42.8% and the right coronary artery in 36.8% of all cases. Four primary stent deployment failures occurred and implantation was successful in 289 (97.4%) of 266 stents. No death and no Q‐wave myocardial infarction or emergency CABG occurred during hospital stay. Clinical success, defined as successful deployment without procedural or clinical event, was achieved in 230 (98.4%) of 241 patients. One‐year clinical follow‐up shows a low need for target lesion revascularization (17/237 [7.1%] patients) and a 15.8% rate of major adverse cardiac events (36/237 patients). The clinical and angiographic outcomes of our study suggest that the hybrid, amorphous hydrogenated silicon carbide coated design is promising and merits further evaluation in larger clinical trials. (J Interven Cardiol 2001; 14: 1–5)Keywords
This publication has 13 references indexed in Scilit:
- Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)The Lancet, 1998
- Patterns and Mechanisms of In-Stent RestenosisCirculation, 1996
- Stents for intracoronary placement: Current status and future directionsJACC, 1996
- Three-Year Follow-up after Implantation of Metallic Coronary-Artery StentsNew England Journal of Medicine, 1996
- Endovascular Stent Design Dictates Experimental Restenosis and ThrombosisCirculation, 1995
- Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure.Circulation, 1994
- Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration.Circulation, 1993
- Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.Circulation, 1991
- Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 PatientsJACC, 1988
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987